Table 2.

Death rates (per 1,000 person-years) in men and women according to baseline glucose tolerance groups

	NDD				NGT*
	Men (n = 290)		Women (n = 308)		Men (n = 272)		Women (n = 220)
	pyrs = 4,908		pyrs = 5,787		pyrs = 5,734		pyrs = 4,886
	n	Rate# (95% CI)	n	Rate# (95% CI)	n	Rate# (95% CI)	n	Rate# (95% CI)
CVD	86	17.5 (13.8–21.2)	78	13.5 (10.5–16.5)	29	5.3 (3.3–7.2)	8	3.5 (0.9–6.1)
CHD	41	8.4 (5.8–10.9)	45	7.8 (5.7–10.4)	18	3.3 (1.8–4.9)	1	0.3 (0.2–1.1)
Stroke	45	9.2 (6.5–11.8)	33	5.7 (3.8–7.6)	11	2.0 (0.8–3.1)	7	3.0 (0.6–5.4)
Non-CVD	95	19.4 (15.5–23.2)	79	13.7 (10.6–16.7)	43	8.1 (5.6–10.5)	20	5.7 (2.7–8.7)
Cancer	28	5.7 (3.6–7.8)	20	3.5 (2.1–5.3)	28	5.3 (3.3–7.2)	13	2.7 (1.5–4.4)
Renal failure	24	4.9 (3.1–7.3)	28	4.8 (3.2–7.0)	2	0.4 (0–1.5)	1	0.2 (0–1.1)
Infection	18	3.7 (2.2–5.8)	10	1.7 (0.8–3.2)	3	0.6 (0.1–1.7)	1	1.0 (0.3–2.1)
COPD	4	0.8 (0.2–2.1)	5	0.9 (0.3–2.0)	7	1.4 (0.6–2.9)	0
Cirrhosis	8	1.6 (0.7–3.2)	2	0.4 (0–1.2)	1	0.2 (0–1.0)	1	0.3 (0–1.1)
Injury	7	1.4 (0.6–2.9)	7	1.2 (0.5–2.5)	2	0.3 (0–1.4)	3	0.8 (0.1–1.6)
Diabetes§	3	0.6 (0.1–1.8)	4	0.7 (0.2–1.7)	0	0	0	0
Unknown†	3	0.6 (0.1–1.7)	3	0.5 (0.1–1.5)	0	0	1	0.4 (0–0.9)
All cause	181	36.9 (31.5–42.3)	157	27.1 (22.9–31.4)	72	13.3 (10.2–16.5)	28	9.2 (7.8–10.6)

95% CIs calculated using normal approximation from the SAS STDRATE procedure. COPD, chronic obstructive pulmonary disease; n, number of persons or deaths in each group; pyrs, person-years.

*Rates in NGT group are standardized directly to the age distribution of the corresponding NDD group using the SAS STDRATE procedure;

#number of deaths/1,000 person-years;

§deaths from ketoacidosis or hyperosmolar coma;

†unknown causes.